Skip to main content

$0.205 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
2 July 2025 at 10:47am
Register to track RAP and receive email alerts.
Subject
RAP Ann: ResApp receives $801,738 R&D tax incentive refund and grant

RAP Ann: ResApp strengthens patent position in Europe

RAP Ann: Quarterly Activities Report and Appendix 4C

RAP Ann: Quarterly Results and Investor Conference Call Notification

RAP Ann: Appendix 3G

RAP Ann: ResApp appoints VP, Commercial to progress growth strategy

RAP Ann: SleepCheck Launched on Select Android Devices

RAP Ann: ResApp Terminates MOU with RB

RAP Ann: Software updates for ResAppDx to underpin growth

RAP Ann: S&P DJI Announces December 2020 Quarterly Rebalance

RAP Ann: Appointment of Joint Company Secretary

RAP Ann: Change of Director's Interest Notice

RAP Ann: Appendix 3G

RAP Ann: Notification of Change of Auditor

RAP Ann: Adoption of New Constitution

RAP Ann: Results of Annual General Meeting

RAP Ann: Annual General Meeting Presentation

RAP Ann: 2020 Letter to Shareholders

RAP Ann: Positive engagement with US FDA following SleepCheck Pre-Sub

RAP Ann: ResAppDx to be integrated into WMA telehealth application

RAP Ann: Medgate to pilot ResAppDx for telehealth across Europe

RAP Ann: Quarterly Activities Report and Appendix 4C

RAP Ann: ResAppDx launched on select Android devices

RAP Ann: Quarterly Results and Investor Conference Call Notification

RAP Ann: Notice of Annual General Meeting/Proxy Form

RAP Ann: AstraZeneca to use new ResApp software in study - Revised

RAP Ann: Pause in Trading

RAP Ann: AstraZeneca to use new ResApp software in clinical study

RAP Ann: Partners with largest Australian consumer healthcare network

Register to track RAP and receive email alerts.

Similar Companies

4DX
ALC
CGS
IME
M7T
MDR
PCK
PKS
PME